Abstract
Intracranial atherosclerosis (ICAD) is responsible for a significant proportion of ischemic strokes worldwide. Conservative medical management is the appropriate first step in the treatment of ICAD. The clinical presentation of ICAD is heterogenous, with ischemia resulting from more than one mechanism. Delineating the mechanism of ischemia needs careful clinical analysis and usually necessitates multimodal imaging. An endovascular treatment approach based on the mechanism of stroke may be beneficial for select patients. Patient selection will be a critical factor in the design of future ICAD clinical trials.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Lee JS, Im DS, An Y-S, Hong JM, Gwag BJ, Joo IS. Chronic cerebral hypoperfusion in a mouse model of Alzheimer’s disease: an additional contributing factor of cognitive impairment. Neurosci Lett. 2011;489(2):84–8. doi:10.1016/j.neulet.2010.11.071.
Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke. 1995;26(1):14–20.
Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993–1003. doi:10.1056/NEJMoa1105335.
Wong LKS. Global burden of intracranial atherosclerosis. Int J Stroke. 2006;1(3):158–9. doi:10.1111/j.1747-4949.2006.00045.x.
Choi H-Y, Ye BS, Ahn SH, et al. Characteristics and the fate of intraluminal thrombus of the intracranial and extracranial cerebral arteries in acute ischemic stroke patients. Eur Neurol. 2009;62(2):72–8.
Chaturvedi S, Turan TN, Lynn MJ, et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology. 2007;69(22):2063–8. doi:10.1212/01.wnl.0000279338.18776.26.
Adams GJG, Greene JJ, Vick GWG, et al. Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging. Magn Reson Imaging. 2004;22(9):1249–59. doi:10.1016/j.mri.2004.08.020.
Carson AP, Howard G, Burke GL, Shea S, Levitan EB, Muntner P. Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis. Hypertension. 2011;57(6):1101–7. doi:10.1161/HYPERTENSIONAHA.110.168005.
Bley TA, Uhl M, Venhoff N, Thoden J, Langer M, Markl M. 3-T MRI reveals cranial and thoracic inflammatory changes in giant cell arteritis. Clin Rheumatol. 2007;26(3):448–50. doi:10.1007/s10067-005-0160-7.
Waddy SP, Cotsonis G, Lynn MJ, et al. Racial differences in vascular risk factors and outcomes of patients with intracranial atherosclerotic arterial stenosis. Stroke. 2009;40(3):719–25. doi:10.1161/STROKEAHA.108.526624.
Liebeskind DS, Cotsonis GA, Saver JL, et al. Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol. 2011;69(6):963–74. doi:10.1002/ana.22354.
Stevens J, Truesdale KP, Katz EG, Cai J. Impact of body mass index on incident hypertension and diabetes in Chinese Asians, American Whites, and American Blacks: the People’s Republic of China Study and the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2008;167(11):1365–74. doi:10.1093/aje/kwn060.
Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and underused concept. Neurology. 1989;39(9):1246–50.
Caplan LR, Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol. 1998;55(11):1475–82. doi:10.1001/archneur.55.11.1475.
Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med. 2005;352(13):1305–16.
Lee DK, Kim JS, Kwon SU, Yoo S-H, Kang D-W. Lesion patterns and stroke mechanism in atherosclerotic middle cerebral artery disease: early diffusion-weighted imaging study. Stroke. 2005;36(12):2583–8. doi:10.1161/01.STR.0000189999.19948.14.
Ryoo S, Park JH, Kim SJ, et al. Branch occlusive disease: clinical and magnetic resonance angiography findings. Neurology. 2012;78(12):888–96. doi:10.1212/WNL.0b013e31824c4699.
Holmstedt CA, Turan TN, Chimowitz MI. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2013;12(11):1106–14. doi:10.1016/S1474-4422(13)70195-9.
Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation. 2006;113(4):555–63. doi:10.1161/CIRCULATIONAHA.105.578229.
Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383:333–41. doi:10.1016/S0140-6736(13)62038-3.
Khan A, Kasner SE, Lynn MJ, Chimowitz MI. Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke. Stroke. 2012;43(5):1230–3. doi:10.1161/STROKEAHA.111.641696.
Ois A, Gomis M, Rodriguez-Campello A, et al. Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke. Stroke. 2008;39(6):1717–21. doi:10.1161/STROKEAHA.107.505438.
Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol. 2000;21(4):643–6.
Kang D-W, Kwon SU, Yoo S-H, et al. Early recurrent ischemic lesions on diffusion-weighted imaging in symptomatic intracranial atherosclerosis. Arch Neurol. 2007;64(1):50–4. doi:10.1001/archneur.64.1.50.
Cho K-H, Kang D-W, Kwon SU, Kim JS. Location of single subcortical infarction due to middle cerebral artery atherosclerosis: proximal versus distal arterial stenosis. J Neurol Neurosurg Psychiatry. 2009;80(1):48–52. doi:10.1136/jnnp.2007.143354.
Feldmann EE, Wilterdink JLJ, Kosinski AA, et al. The stroke outcomes and neuroimaging of intracranial atherosclerosis (SONIA) trial. Neurology. 2007;68(24):2099–106. doi:10.1212/01.wnl.0000261488.05906.c1.
de Andrade SPC, Brucki SMD, Bueno OFA, Siqueira Neto JI. Neuropsychological performance in patients with subcortical stroke. Arq Neuropsiquiatr. 2012;70(5):341–7.
Saczynski JS, Sigurdsson S, Jonsdottir MK, et al. Cerebral infarcts and cognitive performance: importance of location and number of infarcts. Stroke. 2009;40(3):677–82. doi:10.1161/STROKEAHA.108.530212.
Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol. 2005;26(5):1012–21.
Nguyen-Huynh MN, Wintermark M, English J, et al. How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke. 2008;39(4):1184–8. doi:10.1161/STROKEAHA.107.502906.
Swartz RH, Bhuta SS, Farb RI, et al. Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI. Neurology. 2009;72(7):627–34. doi:10.1212/01.wnl.0000342470.69739.b3.
Ryu C-WC, Jahng G-HG, Kim E-JE, Choi W-SW, Yang D-MD. High resolution wall and lumen MRI of the middle cerebral arteries at 3 tesla. Cerebrovasc Dis. 2009;27(5):433–42.
Diethrich EB, Margolis MP, Reid DB, et al. Virtual histology intravascular ultrasound assessment of carotid artery disease: the Carotid Artery Plaque Virtual Histology Evaluation (CAPITAL) study. J Endovasc Ther. 2007;14(5):676–86. doi:10.1583/1545-1550(2007)14[676:VHIUAO]2.0.CO;2.
Xu W-H, Li M-L, Gao S, et al. Middle cerebral artery intraplaque hemorrhage: prevalence and clinical relevance. Ann Neurol. 2012;71(2):195–8. doi:10.1002/ana.22626.
Vergouwen MDIM, Silver FLF, Mandell DMD, Mikulis DJD, Swartz RHR. Eccentric narrowing and enhancement of symptomatic middle cerebral artery stenoses in patients with recent ischemic stroke. Arch Neurol. 2011;68(3):338–42. doi:10.1001/archneurol.2011.20.
Higashida RT, Furlan AJ, Roberts H, et al. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003;34(8):e109–37. doi:10.1161/01.STR.0000082720.85129.0A.
Powers WJ, Clarke WR, Grubb RL, et al. Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial. JAMA. 2011;306(18):1983–92. doi:10.1001/jama.2011.1610.
Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med. 1985;313(19):1191–1200. doi:10.1056/NEJM198511073131904.
Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology. 2006;66(8):1187–91. doi:10.1212/01.wnl.0000208404.94585.b2.
Marks MP, Wojak JC, Al-Ali F, et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke. 2006;37(4):1016–20. doi:10.1161/01.STR.0000206142.03677.c2.
Marks MP, Marcellus ML, Do HM, et al. Intracranial angioplasty without stenting for symptomatic atherosclerotic stenosis: long-term follow-up. AJNR Am J Neuroradiol. 2005;26(3):525–30.
Castaneda-Zuniga WR, Formanek A, Tadavarthy M, et al. The mechanism of balloon angioplasty. Radiology. 1980;135(3):565–71.
Sundt TM, Smith HC, Campbell JK, Vlietstra RE, Cucchiara RF, Stanson AW. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc. 1980;55(11):673–80.
O’Leary DHD, Clouse MEM. Percutaneous transluminal angioplasty of the cavernous carotid artery for recurrent ischemia. AJNR Am J Neuroradiol. 1984;5(5):644–5.
Purdy PDP, Devous MDM, Unwin DHD, Giller CAC, Batjer HHH. Angioplasty of an atherosclerotic middle cerebral artery associated with improvement in regional cerebral blood flow. AJNR Am J Neuroradiol. 1990;11(5):878–80.
Takis C, Kwan ES, Pessin MS, Jacobs DH, Caplan LR. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol. 1997;18(9):1661–8.
Connors JJ, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg. 1999;91(3):415–23.
Terada T, Tsuura M, Matsumoto H, et al. Endovascular therapy for stenosis of the petrous or cavernous portion of the internal carotid artery: percutaneous transluminal angioplasty compared with stent placement. J Neurosurg. 2003;98(3):491–7.
Johnston S, Selvin S. The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology. 1998;50(5):143–8.
Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke. 2007;38(6):2001–23. doi:10.1161/STROKEAHA.107.183689.
Miao Z, Jiang L, Wu H, et al. Randomized controlled trial of symptomatic middle cerebral artery stenosis: endovascular versus medical therapy in a chinese population. Stroke. 2012;43(12):3284–90. doi:10.1161/STROKEAHA.112.662270.
Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation. 2013;127(1):e6–245. doi:10.1161/CIR.0b013e31828124ad.
Wojak JC, Dunlap DC, Hargrave KR, DeAlvare LA, Culbertson HS, Connors JJ. Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol. 2006;27(9):1882–92.
Nguyen TN, Zaidat OO, Gupta R, et al. Balloon angioplasty for intracranial atherosclerotic disease: periprocedural risks and short-term outcomes in a multicenter study. Stroke. 2011;42(1):107–11. doi:10.1161/STROKEAHA.110.583245.
Hussain MS, Fraser JF, Abruzzo T, et al. Standard of practice: endovascular treatment of intracranial atherosclerosis. J Neurointerv Surg. 2012;4(6):397–406. doi:10.1136/neurintsurg-2012-010405.
Siddiq F, Vazquez G, Memon MZ, et al. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a Multicenter study. Stroke. 2008;39(9):2505–10. doi:10.1161/STROKEAHA.108.515361.
Mazighi M, Yadav JS, Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke. 2008;39(6):1766–9. doi:10.1161/STROKEAHA.107.500587.
Qureshi AI, Kirmani JF, Hussein HM, et al. Early and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosis. Neurosurgery. 2006;59(5):1044–51. doi:10.1227/01.NEU.0000245593.54204.99. discussion 1051.
Abou-Chebl A, Bashir Q, Yadav JS. Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke. 2005;36(12):e165–8. doi:10.1161/01.STR.0000190893.74268.fd.
Boulos AS, Agner C, Deshaies EM. Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease. Neurol Res. 2005;27 Suppl 1:S95–102. doi:10.1179/016164105X35459.
Roy PP, Bonello LL, Torguson RR, et al. Temporal relation between clopidogrel cessation and stent thrombosis after drug-eluting stent implantation. Am J Cardiol. 2009;103(6):801–5. doi:10.1016/j.amjcard.2008.11.038.
Palmerini T, Biondi-Zoccai G, Riva Della D, et al. Stent thrombosis with drug-eluting stents: is the paradigm shifting? J Am Coll Cardiol. 2013;62(21):1915–21. doi:10.1016/j.jacc.2013.08.725.
Park S, Lee D-G, Chung W-J, Lee DH, Suh DC. Long-term outcomes of drug-eluting stents in symptomatic intracranial stenosis. Neurointervention. 2013;8(1):9. doi:10.5469/neuroint.2013.8.1.9.
Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38(3):881–7. doi:10.1161/01.STR.0000257963.65728.e8.
Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008;70(17):1518–24. doi:10.1212/01.wnl.0000306308.08229.a3.
Zaidat OO, Castonguay AC, Nguyen TN, et al. Impact of SAMMPRIS on the future of intracranial atherosclerotic disease management: polling results from the ICAD symposium at the International Stroke Conference. J Neurointerv Surg. 2014;6:225–30. doi:10.1136/neurintsurg-2013-010667.
Yu SCHS, Leung TWHT, Lee KTK, Hui JWYJ, Wong LKSL. Angioplasty and stenting of atherosclerotic middle cerebral arteries with Wingspan: evaluation of clinical outcome, restenosis, and procedure outcome. AJNR Am J Neuroradiol. 2011;32(4):753–8. doi:10.3174/ajnr.A2363.
Kurre W, Berkefeld J, Brassel F, et al. In-hospital complication rates after stent treatment of 388 symptomatic intracranial stenoses: results from the INTRASTENT multicentric registry. Stroke. 2010;41(3):494–8. doi:10.1161/STROKEAHA.109.568063.
The SSYLVIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke. 2004;35(6):1388–92. doi:10.1161/01.STR.0000128708.86762.d6.
Derdeyn CP, Fiorella D, Lynn MJ, et al. Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial. Neurosurgery. 2013;72(5):777–95. doi:10.1227/NEU.0b013e318286fdc8. discussion 795.
Fiorella D, Derdeyn CP, Lynn MJ, et al. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke. 2012;43(10):2682–8. doi:10.1161/STROKEAHA.112.661173.
Chimowitz MI, Fiorella D, Derdeyn CP, et al. Response to critique of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz. Stroke. 2012;43(10):2806–9. doi:10.1161/STROKEAHA.112.661041.
Gonzalez NR, Liebeskind DS, Dusick JR, Mayor F, Saver J. Intracranial arterial stenoses: current viewpoints, novel approaches, and surgical perspectives. Neurosurg Rev. 2013;36(2):175–84. doi:10.1007/s10143-012-0432-z.
Mori T, Fukuoka M, Kazita K, Mori K. Follow-up study after intracranial percutaneous transluminal cerebral balloon angioplasty. AJNR Am J Neuroradiol. 1998;19(8):1525–33.
Disclosures
Funding sources: None.
Conflict of Interest None.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Teleb, M.S., Asif, K., Castonguay, A.C., Zaidat, O.O. (2015). Endovascular Treatment of Intracranial Atherosclerosis. In: Edgell, R., Savitz, S., Dalfino, J. (eds) Neurointervention in the Medical Specialties. Current Clinical Neurology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1942-0_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1942-0_5
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1941-3
Online ISBN: 978-1-4939-1942-0
eBook Packages: MedicineMedicine (R0)